Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 7 Fib (≤ 1.0 g/L) level before and after treatment (mean ± SD)

		Fib (g/L)	PT (s)	PLT (109/L)	TBIL (μmol/L)	ALB (g/L)
Research group 10 cases	Before treatment	0.77 ± 0.19	26.59 ± 5.39	62.80 ± 33.19	198.40 ± 123.37	29.60 ± 3.82
	After treatment	1.29 ± 0.35	23.29 ± 5.35	54.80 ± 37.42	77.85 ± 39.21	35.31 ± 5.07
Control group 10 cases	Before treatment	0.79 ± 0.18	31.49 ± 8.68	73.27 ± 57.34	245.57 ± 193.69	30.15 ± 6.61
	After treatment	0.90 ± 0.36	39.08 ± 22.78	70.93 ± 54.06	173.47 ± 149.30	35.86 ± 5.71
P value		0.013	0.043	0.421	0.061	0.807

PT and Fib were significantly higher in the research group than in the control group after treatment.